Ballinghoff T; Bain KT; Matos A; Bardolia C; Turgeon J; Nishita Shah Amin
Abstract
The benefits of opioid use in older adults to manage chronic non-cancer pain must outweigh the risks as these individuals are more susceptible to the side effects and drug interactions associated with opioids. Pharmacogenomic testing supports clinicians in selecting appropriate opioid therapy while minimizing these risks.
